Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma

Table 4 Serum fibroblast growth factor 19 levels according to variables in the hepatocellular carcinoma group

		FGF-19 pg/mL (mean ± SD)	P value
Size	< 2 cm	219.9 ± 51.79	0.254
	2-3 cm	229.2 ± 36.06
	> 5 cm	253.72 ± 44.39
Number	Single	234.17 ± 36.38	0.885
	2 - 3	242.28 ± 45.69
	Multiple	233.74 ± 44.22
Portal vein thrombosis	No	230.55 ± 39.13	0.235
	Yes	250.2 ± 44.08
Right upper quadrant pain	No	237.171 ± 41.026	0.885
	Yes	234.744 ± 43.163
Weight loss	No	229.132 ± 34.285	0.106
	Yes	256.550 ± 52.793
Pruritus	No	239.518 ± 39.170	0.505
	Yes	227.988 ± 47.214
Jaundice	No	226.182 ± 29.468	0.118
	Yes	249.86 ± 50.48
Fever	No	237.668 ± 40.531	0.834
	Yes	234.33 ± 43.54
Oedema	No	228.945 ± 37.054	0.16
	Yes	251.44 ± 46.12

FGF-19: Fibroblast growth factor 19.